Literature DB >> 16120924

A comparison of whole-body MRI and CT for the staging of lymphoma.

D D Brennan1, T Gleeson, L E Coate, C Cronin, D Carney, S J Eustace.   

Abstract

OBJECTIVE: Our objective was to compare whole-body MRI and CT for the staging of lymphoma.
CONCLUSION: Whole-body MRI represents an alternative to CT in the staging of lymphoma, with an ability to stage disease, identify lymph nodes greater than 1.2 cm, and the additional ability to evaluate for the presence or absence of disease spread to bone marrow. CT allows detection of more nodes (< 1.2 cm) than MRI but this does not alter tumor stage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16120924     DOI: 10.2214/ajr.185.3.01850711

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  24 in total

Review 1.  [Whole body MRI--diagnostic strategy of the future?].

Authors:  M Goyen; H-P Schlemmer
Journal:  Radiologe       Date:  2007-10       Impact factor: 0.635

2.  Whole body MRI with qualitative and quantitative analysis of DWI for assessment of bone marrow involvement in lymphoma.

Authors:  Annalisa Balbo-Mussetto; Chiara Saviolo; Alberto Fornari; Daniela Gottardi; Massimo Petracchini; Annalisa Macera; Chiara Valentina Lario; Teresa Gallo; Corrado Tarella; Stefano Cirillo
Journal:  Radiol Med       Date:  2017-04-18       Impact factor: 3.469

3.  ¹⁸F-FDG PET/CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/hypopharyngeal carcinoma: a comparative study.

Authors:  Sheng-Chieh Chan; Hung-Ming Wang; Tzu-Chen Yen; Chien-Yu Lin; Shy-Chyi Chin; Chun-Ta Liao; Yau-Yau Wai; Jiun-Jie Wang; Shu-Hang Ng
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-13       Impact factor: 9.236

4.  Clinical utility of ¹⁸F FDG-PET/CT in the detection of bone marrow disease in Hodgkin's lymphoma.

Authors:  S Muzahir; M Mian; I Munir; M K Nawaz; Z S Faruqui; K A Mufti; H Bashir; N Uddin; N Siddiqui; A U R Maaz; M T Mahmood
Journal:  Br J Radiol       Date:  2012-01-03       Impact factor: 3.039

5.  Can diffusion-weighted whole-body MRI replace contrast-enhanced CT for initial staging of Hodgkin lymphoma in children and adolescents?

Authors:  Rodrigo Regacini; Andrea Puchnick; Flavio Augusto Vercillo Luisi; Henrique Manoel Lederman
Journal:  Pediatr Radiol       Date:  2018-01-23

6.  Whole-body MRI and PET-CT in the management of cancer patients.

Authors:  Gerwin P Schmidt; Alexander R Haug; Stefan O Schoenberg; Maximilian F Reiser
Journal:  Eur Radiol       Date:  2006-03-15       Impact factor: 5.315

7.  Cellular density evaluation for malignant lymphoma using equivalent cross-relaxation rate imaging - initial experience.

Authors:  Hideyuki Nishiofuku; Shigeru Matsushima; Yoshitaka Inaba; Hidekazu Yamaura; Yozo Sato; Yasuo Morishima; Kimihiko Kichikawa
Journal:  Korean J Radiol       Date:  2010-04-29       Impact factor: 3.500

Review 8.  Whole-body diffusion-weighted imaging for staging malignant lymphoma in children.

Authors:  Thomas C Kwee; Taro Takahara; Malou A Vermoolen; Marc B Bierings; Willem P Mali; Rutger A J Nievelstein
Journal:  Pediatr Radiol       Date:  2010-07-30

Review 9.  [Differential diagnosis and diagnostic strategies of lymphadenopathy].

Authors:  W Jung; L Trümper
Journal:  Internist (Berl)       Date:  2008-03       Impact factor: 0.743

10.  Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET.

Authors:  Hugo J A Adams; Thomas C Kwee; Malou A Vermoolen; Bart de Keizer; John M H de Klerk; Judit A Adam; Rob Fijnheer; Marie José Kersten; Jaap Stoker; Rutger A J Nievelstein
Journal:  Eur Radiol       Date:  2013-04-17       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.